You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes

LOGAN, BETH A. MA*; BROWN, MARK S. MD, MSPH; HAYES, MARIE J. PhD*,‡

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e31827feea4
Substance Abuse and Pregnancy
Abstract

Recent rise in rates of opiate replacement therapy among pregnant women have resulted in increasing number of infants requiring treatment for neonatal abstinence syndrome (NAS). Short-term and long-term developmental outcomes associated with prenatal opiate exposure are discussed, including symptoms and severity of NAS, and early cognitive and motor delays. Maternal and infant risk factors are discussed, and include patterns of maternal substance use during pregnancy, genetic risk, polysubstance exposure pharmacological treatment for NAS and breastfeeding. The importance of characterizing corollary environmental risk factors is also considered.

Author Information

*Graduate School of Biomedical Sciences and Department of Psychology, University of Maine, Orono, Maine

Eastern Maine Medical Center

Eastern Maine Healthcare Systems, Bangor, Maine

The authors declare that they have nothing to disclose.

M.J.H received financial support from NIH DA4806.

Correspondence: Mark S. Brown, MD, MSPH, Kelley 6, Bangor, ME. E-mail: mbrown@emh.org

© 2013 Lippincott Williams & Wilkins, Inc.